A phase 2, multicenter study to evaluate the efficacy and safety using autologous tumor infiltrating lymphocytes (LN-145) in patients with recurrent, metastatic, or persistent cervical carcinoma

Amir A Jazaeri; Robert P Edwards; Robert Michael Wenham; KOJI MATSUO; Gini F Fleming; David M O'Malley; Brian M Slomovitz; Bradley J Monk; Robert James Brown; Samuel Suzuki; Igor Gorbatchevsky; Maria Fardis; Emese Zsiros

doi:10.1200/JCO.2018.36.15_suppl.TPS5604

Back

A phase 2, multicenter study to evaluate the efficacy and safety using autologous tumor infiltrating lymphocytes (LN-145) in patients with recurrent, metastatic, or persistent cervical carcinoma

Journal article

Peer reviewed

A phase 2, multicenter study to evaluate the efficacy and safety using autologous tumor infiltrating lymphocytes (LN-145) in patients with recurrent, metastatic, or persistent cervical carcinoma

Amir A Jazaeri, Robert P Edwards, Robert Michael Wenham, KOJI MATSUO, Gini F Fleming, David M O'Malley, Brian M Slomovitz, Bradley J Monk, Robert James Brown, Samuel Suzuki, …

Journal of clinical oncology, Vol.36(15_suppl), pp.TPS5604-TPS5604

2018-05-20

DOI: https://doi.org/10.1200/JCO.2018.36.15_suppl.TPS5604

Metrics

18 Record Views

3 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.6 Immunology; 1.6.214 PD-1
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: A phase 2, multicenter study to evaluate the efficacy and safety using autologous tumor infiltrating lymphocytes (LN-145) in patients with recurrent, metastatic, or persistent cervical carcinoma
Creators: Amir A Jazaeri - University of Virginia, Charlottesville, VA
Robert P Edwards - Magee-Womens Hospital of UPMC, Pittsburgh, PA
Robert Michael Wenham - Moffitt Cancer Center, Tampa, FL
KOJI MATSUO - Los Angeles County Hospital/ University of Southern California, Los Angeles, CA
Gini F Fleming - The University of Chicago, Chicago, IL
David M O'Malley - The Ohio State University College of Medicine, Columbus, OH
Brian M Slomovitz - University of Miami, Miami, FL
Bradley J Monk - University of Arizona Cancer Center at Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, AZ
Robert James Brown - Iovance Biotherapeutics, Inc, San Carlos, CA
Samuel Suzuki - Iovance Biotherapeutics, San Carlos, CA
Igor Gorbatchevsky - Iovance Biotherapeutics, Inc., San Carlos, CA
Maria Fardis - Iovance Biotherapeutics, San Carlos, CA
Emese Zsiros - Rosewel Park Cancer Institute, Buffalo, NY
Publication Details: Journal of clinical oncology, Vol.36(15_suppl), pp.TPS5604-TPS5604
Academic Unit: Miller School of Medicine; UMMG Dept of Obstetrics & Gynecology
Language: English
Resource Type: Journal article
Record Identifier: 991031599630202976